Black Swan Pharmaceuticals, Inc. — Form D
Black Swan Pharmaceuticals, Inc. of WAKE FOREST, NC, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-29. The offering totals $3.0M, of which $1.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-09-29
- Form: D
- Accession: 0001808761-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.9M
- Remaining: $1.1M
- Investors: 5
- Date of first sale: 2021-09-14
- Revenue range: Decline to Disclose
- SEC file number: 021-415024
Issuer
- Name: Black Swan Pharmaceuticals, Inc.
- CIK: 0001808761
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 9008 LAURA LAKE DRIVE, WAKE FOREST, NC, 27587
- Phone: 919-612-4363
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Anthony Akkari | Director | Wake Forest, NC |
| Julian Arbuckle | Director | Wake Forest, NC |
| Steve Arnott | Director | Wake Forest, NC |
| Om Dhingra | Director | Raleigh, NC |
| Craig Metz | Director | Wake Forest, NC |
| Craig Metz | Executive Officer | Wake Forest, NC |
Other filings by this issuer (1)
More